We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




3D Mammography Significantly Reduces Breast Biopsies

By HospiMedica International staff writers
Posted on 01 Apr 2019
Digital breast tomosynthesis (DBT) considerably reduces the number of women who undergo breast biopsy following an abnormal mammogram, according to a new study.

Researchers at Seacroft Hospital (Leeds, United Kingdom) and Loughborough University (LBORO; United Kingdom) conducted a prospective study that included 30,933 women who had a full-field digital mammography (FFDM) screening between 2015 and 2016; recalled women also underwent DBT and biopsy. More...
Readers blinded to biopsy results analyzed DBT images in isolation and then in conjunction with FFDM images, and any additional mammographic or ultrasound images. The aim of the study was to evaluate the benign biopsy rate of DBT versus that of FFDM.

The results revealed that 1,470 women were recalled for further imaging (a 4.8% recall rate) to assess an abnormality. A final recall group of 827 women (after exclusions) required 571 biopsies, for a biopsy rate of 69%. While biopsy detected 142 cancers, in the other 429 biopsies performed, the suspicious lesion was not cancerous, a benign biopsy rate of 75%. Inclusion of DBT would have reduced the number of biopsies performed on recalled women from 571 to 298--while still detecting the 142 cancers--for a biopsy rate of 36%, and a benign biopsy rate of 52%. The study was published on March 19, 2019, in Radiology.

“The thin slice images of the breast taken with DBT reduce the effect of tissue overlap, which often leads to cancers being missed or to women who don't have breast cancer being recalled for diagnostic imaging,” said lead author Nisha Sharma, MB, ChB, director of breast screening at Seacroft Hospital. “DBT allows for improved reader accuracy and confidence in determining if a mammographic abnormality is concerning or not, and reduces harm to women through fewer false positive biopsies without any reduction in the cancer detection rate.”

DBT acquires multiple images over a limited angular range to produce a set of reconstructed images, which can then be viewed individually or sequentially in a cine loop, and in a three-dimensional (3D) image of the breast, which can viewed in narrow slices, similar to CT scans. While in conventional 2D mammography overlapping tissues can mask suspicious areas, 3D images eliminate the overlap, making abnormalities easier to recognize. It is estimated that 3D DBT will replace conventional mammography within ten years.

Related Links:
Seacroft Hospital
Loughborough University


Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Radiofrequency Generator
GX1
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.